The TRM marker CD103 is a tissue homing molecule important for effector T cell trafficking as well as a promising prognosis biomarker for assessment of tumor-reactive TILS in various types of cancer, such as lung cancer, ovarian cancer and cervical cancers. The gene discussed is ITGAE; the disease is ovarian carcinoma.